Philanthropy

Accelerating a New Frontier in Motion-Based Medicine

Every major advance in medicine begins before the evidence exists.

SeaKing Solace was founded to investigate a scientific question that has not yet been rigorously explored: can carefully characterized natural multidimensional motion influence human physiology in ways that support measurable neurological and autonomic responses?

The answer cannot be assumed. It must be discovered through careful science.

That discovery begins with Phase 1 of the SeaKing Solace research program.

01

The funding gap

Why Philanthropy Matters

The most transformative scientific discoveries often begin long before conventional funding becomes available.

Early-stage translational research faces a difficult funding gap. Preliminary human evidence is often required before traditional research funding becomes competitive, yet that evidence cannot exist until the first rigorous studies are conducted.

SeaKing Solace was created to bridge that gap.

Can natural multidimensional motion be objectively measured, synchronized with physiological responses, and systematically characterized in human participants?

Philanthropic support makes it possible to generate the foundational human evidence needed for later clinical research.

Research progression

Phase 1 is the current funding stage

  1. 01Observation
  2. 02Scientific Foundation
  3. 03Phase 1 Human ResearchCurrent funding stage
  4. 04Controlled Validation
  5. 05Clinical Research
  6. 06Future Clinical Technology
SeaKing Solace has progressed from observation and scientific foundation to the current Phase 1 human research funding stage, followed by later controlled validation, clinical research, and potential future clinical technology.

02

The origin

Why We Began

SeaKing Solace began with a simple observation.

During time spent aboard a sailboat, our founder's son, who lives with autism, experienced a level of calm, engagement, and interaction that had not been observed in other settings.

Rather than assuming the cause, that experience raised a scientific question: could aspects of natural multidimensional motion influence the nervous system in measurable ways?

SeaKing Solace was created not to validate an anecdote, but to test that question rigorously through independent clinical research.

The mission has since grown into a broader scientific effort to understand how carefully characterized natural motion may contribute to future advances in neurological and autonomic medicine.

03

Defined research budget

The Phase 1 Research Program

A comprehensive human translational research program combining academic clinical research with a dedicated natural-motion research platform.

Combined Phase 1 budget

Approximately $4.74 Million

Documented total: $4,740,636

University Clinical Research Program

$1.16M

Exact budget: $1,155,536

Supports the academic clinical research infrastructure required to execute Phase 1, including Principal Investigator oversight, research management, study coordination, biostatistics, data management, participant remuneration, IRB and regulatory oversight, research operations, statistical analysis, and scientific publication.

The university budget includes approximately $714,000 in personnel-related costs, together with participant, travel, supplies, IRB, and institutional research costs.

SeaKing Natural Motion Research Platform

$3.59M

Exact budget: $3,585,100

Supports the vessel-based research environment, instrumentation, staffing, safety systems, maintenance, and operational infrastructure required to conduct repeated instrumented human research sessions in naturally occurring multidimensional motion.

  • Research platform acquisition
  • Motion characterization
  • Physiological monitoring
  • Data infrastructure
  • Clinical operations
  • Vessel safety and communications
  • Dockage and maintenance
  • Study readiness and research staffing

04

Six defined workstreams

Fund a Specific Part of Phase 1

Philanthropic partners may support the overall Phase 1 program or choose to underwrite a specific scientific or operational workstream.

Total goal

$4,740,636

Raised

$0

Remaining

$4,740,636

Funding workstream

University Clinical Research

$1.16M

Exact goal: $1,155,536

Funds the academic research infrastructure required to conduct a rigorous human clinical study.

Raised: $0

0% funded

Remaining: $1,155,536

What this unlocks
  • Principal Investigator oversight
  • Project management
  • Study coordination
  • Data management
  • Biostatistics
  • Participant support
  • Regulatory and IRB functions
  • Institutional research operations

Funding workstream

Natural Motion Research Platform

$1,540,000

Exact goal: $1,540,000

Supports acquisition and deployment of the vessel-based research platform required to study naturally occurring multidimensional motion under real-world conditions.

Raised: $0

0% funded

Remaining: $1,540,000

What this unlocks
  • Research vessel acquisition
  • Delivery and deployment
  • Platform reserve and transaction-related acquisition costs

Funding workstream

Measurement & Data Systems

$192,500

Exact goal: $192,500

Builds the synchronized measurement system required to record natural six-degree-of-freedom motion alongside physiological responses.

Raised: $0

0% funded

Remaining: $192,500

What this unlocks
  • 6-DoF motion sensing
  • HR and HRV monitoring
  • Pupillometry
  • Synchronized timestamping
  • Onboard research data systems
  • Secure data integration

Funding workstream

Research Platform Readiness & Safety

$385,000

Exact goal: $385,000

Converts the vessel platform into a repeatable, participant-ready human research environment.

Raised: $0

0% funded

Remaining: $385,000

What this unlocks
  • Research fit-out
  • Participant safety systems
  • Communications
  • Operational qualification
  • Vessel and research insurance
  • Safety equipment
  • Participant-facing readiness

Funding workstream

Clinical & Research Operations

$1.20M

Exact goal: $1,201,500

Keeps the research platform staffed, maintained, clinically ready, and operating across planned study locations throughout Phase 1.

Raised: $0

0% funded

Remaining: $1,201,500

What this unlocks
  • Clinical personnel
  • Vessel operations staff
  • Study-site dockage and utilities
  • Preventive maintenance and haul-outs
  • Sanitation and fuel
  • Participant-area readiness
  • Operational continuity

Funding workstream

Administration & Capital Development

$266,100

Exact goal: $266,100

Supports the financial, organizational, and capital-development infrastructure required to move Phase 1 from preparation to execution.

Raised: $0

0% funded

Remaining: $266,100

What this unlocks
  • Financial administration
  • Capital formation
  • Organizational development
  • Institutional readiness
  • Long-term sustainability
Current PriorityPhase 1 launch preparation

Immediate Priority: Research Leadership & Program Development

Before Phase 1 can begin, substantial scientific, institutional, fundraising, and operational work must occur behind the scenes.

Immediate operational support allows SeaKing Solace leadership to focus full-time on advancing the work required to move the research program from planning into execution.

  • University and clinical partnership development
  • Meetings with major donors and foundations
  • Grant development
  • Scientific publishing
  • Regulatory preparation
  • Study planning
  • Research-platform development
  • Technology integration
  • Institutional relationship management
  • Fundraising and capital formation
  • Phase 1 launch preparation

This support does not fund a future idea in the abstract. It funds the work required now to turn the existing scientific foundation and study architecture into an active human research program.

Support the Current Priority

06

Practical outcomes

What Your Support Makes Possible

Clinical Research

Supports participant recruitment, coordination, monitoring, protocol implementation, and university research operations.

Scientific Research

Supports evidence synthesis, scientific white papers, future manuscripts, analysis, and publication.

Technology

Supports motion sensing, physiological monitoring, synchronized data systems, and future controlled-motion technology.

Collaboration

Supports partnerships across clinical research, neuroscience, rehabilitation, engineering, and data science.

07

Research roadmap

From Natural Motion to Clinical Translation

  1. Phase 1

    Natural Motion Characterization

    Current focus

    Characterize natural multidimensional motion and measure synchronized physiological responses in human participants.

  2. Phase 2

    Controlled Motion Validation

    Reproduce selected motion characteristics under controlled conditions and test whether observed physiological responses can be replicated.

  3. Phase 3

    Clinical Efficacy Research

    Evaluate clinical effects in target populations under controlled study conditions.

  4. Phase 4

    Real-Time Clinical Protocols

    Develop and validate clinically deployable, responsive motion protocols and workflows.

08

Transparency and stewardship

Our Commitment to Scientific Transparency

Every philanthropic partner deserves confidence that research will be conducted with scientific integrity and that resources will be used responsibly.

  • Rigorous study design
  • Transparent reporting
  • Publication of findings
  • Honest reporting of positive, null, and negative results
  • Clear separation of evidence from hypothesis
  • Experienced clinical research oversight
  • Responsible stewardship of philanthropic resources
  • Research updates as major milestones are achieved

Scientific progress depends upon honest evidence, not predetermined conclusions.

View the Science →

09

Inclusive participation

Ways to Support the Research

01

One-Time Giving

Discuss a contribution at any level.

02

Monthly Support

Provide consistent support for ongoing program development.

03

Major Gifts

Support a defined Phase 1 workstream or broader program need.

04

Family Foundations

Align foundation priorities with scientific and operational workstreams.

05

Donor-Advised Funds

Discuss an appropriate pathway with your advisor and SeaKing Solace.

06

Corporate Philanthropy

Support research infrastructure, technology, or program operations.

07

Named Research Support

Explore recognition connected to a qualifying research workstream.

08

Legacy / Estate Giving

Program framework forthcoming.

SeaKing Solace does not currently represent contributions as tax-deductible. Please consult your legal or tax advisor regarding your circumstances and contact us before initiating a gift.

10

Early partnership

Become a Founding Philanthropic Partner

The earliest supporters of SeaKing Solace are helping create the scientific foundation required for the first human research program.

Founding philanthropic partners may support the overall Phase 1 program or choose a specific workstream aligned with their interests.

Whether the contribution helps fund a sensor, participant operations, clinical research personnel, the natural-motion platform, or an entire research workstream, every level of support advances the same objective: generate the human evidence required to determine where the science leads.

Every contribution matters. Foundational research is built through both transformational gifts and communities of individual supporters.

11

Common questions

Philanthropy FAQ

Why does SeaKing Solace need philanthropy?

Early-stage translational research often requires preliminary human evidence before conventional funding becomes competitive. Philanthropy helps fund the foundational research needed to generate that evidence.

Is SeaKing Solace trying to prove that motion works?

No. The research program is designed to test specific hypotheses objectively. Positive, null, and negative findings are all scientifically valuable.

Why not rely entirely on traditional grants?

Traditional grants remain part of the long-term funding strategy, but many programs require preliminary data. Phase 1 is designed to generate the foundational human evidence required for later research.

How will philanthropic funds be used?

Funds support defined scientific and operational workstreams including university clinical research, research-platform acquisition, measurement systems, safety infrastructure, clinical operations, and program development.

Will research results be shared?

SeaKing Solace intends to publish and communicate findings transparently, including results that do not support the original hypothesis.

Can a donor support a specific part of the study?

Yes. Major philanthropic partners may support individual Phase 1 workstreams or broader components of the research program.

Can smaller gifts help?

Yes. Smaller and recurring contributions help support scientific publishing, operational readiness, technology, participant research infrastructure, and continued program development.

Is this page an investment offering?

No. This page describes philanthropic support only. Strategic investment opportunities are handled separately.

The first study

Help Make the First Study Possible

Every significant medical advance began with people willing to support research before certainty existed.

The goal of Phase 1 is not to prove a predetermined conclusion. It is to generate the high-quality human evidence required to determine where the science leads.

Philanthropic partnership can help move SeaKing Solace from a rigorous scientific foundation into active human research.

This page describes philanthropic support only. It is not an investment offering, does not present securities, and does not promise financial or scientific outcomes.